EGFR tyrosine kinase inhibitor (TKI) vs observation
Quality of life · maintenance treatment of epithelial ovarian cancer after first‐line chemotherapy
1 finding from 1 review
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer 2018 · Cochrane Headline outcomes onlyno estimate extracted1 study · 835 participantsVery low